{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:55:20Z","timestamp":1789865720887,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T00:00:00Z","timestamp":1466380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Union Seventh","award":["EU-FP7-PEOPLE-2009-IAPP"],"award-info":[{"award-number":["EU-FP7-PEOPLE-2009-IAPP"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00213-016-4348-0","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T08:21:05Z","timestamp":1466410865000},"page":"3051-3059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Molecular serum signature of treatment resistant depression"],"prefix":"10.1007","volume":"233","author":[{"given":"Tillmann","family":"Ruland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Stocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Rothermundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,20]]},"reference":[{"key":"4348_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.biopsych.2014.10.019","volume":"77","author":"S Bahn","year":"2015","unstructured":"Bahn S, Chan MK (2015) What can we learn about depression from gene expression in peripheral tissues? Biol Psychiatry 77:207\u2013209. doi: 10.1016\/j.biopsych.2014.10.019","journal-title":"Biol Psychiatry"},{"key":"4348_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/sj.npp.1301462","volume":"33","author":"BT Baune","year":"2008","unstructured":"Baune BT, Hohoff C, Berger K et al (2008) Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 33:924\u2013932. doi: 10.1038\/sj.npp.1301462","journal-title":"Neuropsychopharmacology"},{"key":"4348_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2307\/2066277","volume":"9","author":"JR Beniger","year":"1980","unstructured":"Beniger JR, Barnett V, Lewis T (1980) Outliers in statistical data. Contemp Sociol 9:560","journal-title":"Contemp Sociol"},{"key":"4348_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2307\/2346101","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289\u2013300. doi: 10.2307\/2346101","journal-title":"J R Stat Soc Ser B"},{"key":"4348_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.47","volume":"5","author":"JM Biernacka","year":"2015","unstructured":"Biernacka JM, Sangkuhl K, Jenkins G et al (2015) The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response. Transl Psychiatry 5, e553. doi: 10.1038\/tp.2015.47","journal-title":"Transl Psychiatry"},{"key":"4348_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopsych.2014.10.014","volume":"78","author":"C Black","year":"2015","unstructured":"Black C, Miller BJ (2015) Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol Psychiatry 78:28\u201337. doi: 10.1016\/j.biopsych.2014.10.014","journal-title":"Biol Psychiatry"},{"key":"4348_CR7","volume":"5","author":"M Bot","year":"2015","unstructured":"Bot M, Chan MK, Jansen R et al (2015) Serum proteomic profiling of major depressive disorder. Transl Psychiatry 5, e599","journal-title":"Transl Psychiatry"},{"key":"4348_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2710.2007.00846.x","volume":"32","author":"AF Carvalho","year":"2007","unstructured":"Carvalho AF, Cavalcante JL, Castelo MS, Lima MCO (2007) Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Ther 32:415\u2013428","journal-title":"J Clin Pharm Ther"},{"key":"4348_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.2012.191","volume":"38","author":"A Cattaneo","year":"2013","unstructured":"Cattaneo A, Gennarelli M, Uher R et al (2013) Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline \/\u2018predictors\u2019\/ and longitudinal\/\u2018targets\u2019\/. Neuropsychopharmacology 38:377\u2013385","journal-title":"Neuropsychopharmacology"},{"key":"4348_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pneurobio.2014.08.002","volume":"122C","author":"MK Chan","year":"2014","unstructured":"Chan MK, Gottschalk MG, Haenisch F et al (2014) Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Prog Neurobiol 122C:45\u201372. doi: 10.1016\/j.pneurobio.2014.08.002","journal-title":"Prog Neurobiol"},{"issue":"Suppl 1","key":"4348_CR11","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1471-2105-13-S16-S6","volume":"13","author":"T Clough","year":"2012","unstructured":"Clough T, Thaminy S, Ragg S et al (2012) Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs. BMC Bioinforma 13(Suppl 1):S6. doi: 10.1186\/1471-2105-13-S16-S6","journal-title":"BMC Bioinforma"},{"key":"4348_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356. doi: 10.1038\/nrn2297","journal-title":"Nat Rev Neurosci"},{"key":"4348_CR13","unstructured":"Deutsche Gesellschaft f\u00fcr Psychiatrie P und N (DGPPN) (2015) S3-Leitlinie\/Nationale Versorgungsleitlinie Unipolare Depression Langfassung. \u00c4rztliches Zent f\u00fcr Qual der Medizin 1\u2013264. doi: 10.6101\/AZQ\/000239"},{"key":"4348_CR14","unstructured":"R Development Core Team (2013) R: a language and environment for statistical computing. R Found. Stat. Comput. Vienna Austria 0:{ISBN} 3\u2013900051\u201307\u20130."},{"key":"4348_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","volume":"53","author":"M Fava","year":"2003","unstructured":"Fava M (2003) Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53:649\u2013659. doi: 10.1016\/S0006-3223(03)00231-2","journal-title":"Biol Psychiatry"},{"key":"4348_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","volume":"70","author":"A Fekadu","year":"2009","unstructured":"Fekadu A, Wooderson S, Donaldson C et al (2009) A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry 70:177\u2013184","journal-title":"J Clin Psychiatry"},{"key":"4348_CR17","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.4049\/jimmunol.152.5.2430","volume":"152","author":"P Garc\u00eda de Frutos","year":"1994","unstructured":"Garc\u00eda de Frutos P, Dahlb\u00e4ck B (1994) Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. J Immunol 152:2430\u20132437","journal-title":"J Immunol"},{"key":"4348_CR18","doi-asserted-by":"publisher","first-page":"pyu019","DOI":"10.1093\/ijnp\/pyu019","volume":"18","author":"MG Gottschalk","year":"2014","unstructured":"Gottschalk MG, Wesseling H, Guest PC, Bahn S (2014) Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism. Int J Neuropsychopharmacol 18:pyu019. doi: 10.1093\/ijnp\/pyu019","journal-title":"Int J Neuropsychopharmacol"},{"key":"4348_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nature06916","volume":"452","author":"SM Hanash","year":"2008","unstructured":"Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452:571\u2013579. doi: 10.1038\/nature06916","journal-title":"Nature"},{"key":"4348_CR20","volume-title":"Statistical models in S","author":"TJ Hastie","year":"1992","unstructured":"Hastie TJ, Pregibon D (1992) Generalized linear models. In: Chambers JM, Hastie TJ (eds) Statistical models in S. Pacific Grove, CA, USA"},{"key":"4348_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-12-125","volume":"12","author":"MJ Huijbers","year":"2012","unstructured":"Huijbers MJ, Spijker J, Donders ART et al (2012) Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study. BMC Psychiatry 12:1\u201311. doi: 10.1186\/1471-244X-12-125","journal-title":"BMC Psychiatry"},{"key":"4348_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4088\/JCP.09m05853blu","volume":"72","author":"J Hummel","year":"2011","unstructured":"Hummel J, Westphal S, Weber-Hamann B et al (2011) Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. J Clin Psychiatry 72:885\u2013891. doi: 10.4088\/JCP.09m05853blu","journal-title":"J Clin Psychiatry"},{"key":"4348_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","volume":"31","author":"M Iwata","year":"2013","unstructured":"Iwata M, Ota KT, Duman RS (2013) The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 31:105\u2013114. doi: 10.1016\/j.bbi.2012.12.008","journal-title":"Brain Behav Immun"},{"key":"4348_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-62703-360-2_1","volume":"1002","author":"JAJ Jaros","year":"2013","unstructured":"Jaros JAJ, Guest PC, Bahn S, Martins-de-Souza D (2013) Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis. Methods Mol Biol 1002:1\u201311. doi: 10.1007\/978-1-62703-360-2_1","journal-title":"Methods Mol Biol"},{"key":"4348_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jad.2005.03.012","volume":"87","author":"F Kaestner","year":"2005","unstructured":"Kaestner F, Hettich M, Peters M et al (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87:305\u2013311. doi: 10.1016\/j.jad.2005.03.012","journal-title":"J Affect Disord"},{"key":"4348_CR26","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1001\/jama.289.23.3152\\r289\/23\/3152","volume":"289","author":"MB Keller","year":"2003","unstructured":"Keller MB (2003) Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 289:3152\u20133160. doi: 10.1001\/jama.289.23.3152\\r289\/23\/3152 [pii]","journal-title":"JAMA"},{"key":"4348_CR27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4088\/JCP.v66n0101","volume":"66","author":"MB Keller","year":"2005","unstructured":"Keller MB (2005) Issues in treatment-resistant depression. J Clin Psychiatry 66:5\u201312","journal-title":"J Clin Psychiatry"},{"key":"4348_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/msb.2008.61","volume":"4","author":"V Lange","year":"2008","unstructured":"Lange V, Picotti P, Domon B, Aebersold R (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222. doi: 10.1038\/msb.2008.61","journal-title":"Mol Syst Biol"},{"key":"4348_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370\u2013379. doi: 10.1016\/S0893-133X(99)00134-7","journal-title":"Neuropsychopharmacology"},{"key":"4348_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N et al (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966\u2013968. doi: 10.1093\/bioinformatics\/btq054","journal-title":"Bioinformatics"},{"key":"4348_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","volume":"156","author":"RS McIntyre","year":"2014","unstructured":"McIntyre RS, Filteau M-J, Martin L et al (2014) Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord 156:1\u20137. doi: 10.1016\/j.jad.2013.10.043","journal-title":"J Affect Disord"},{"key":"4348_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22\u201334. doi: 10.1038\/nri.2015.5","journal-title":"Nat Rev Immunol"},{"key":"4348_CR33","unstructured":"NCCMH (2010) Depression: the treatment and management of depression in adults (Update)."},{"key":"4348_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4088\/JCP.0707e17","volume":"68","author":"CB Nemeroff","year":"2007","unstructured":"Nemeroff CB (2007) Prevalence and management of treatment-resistant depression. J Clin Psychiatry 68:17\u201325","journal-title":"J Clin Psychiatry"},{"key":"4348_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/mp.2014.180","volume":"20","author":"AB Niculescu","year":"2015","unstructured":"Niculescu AB, Levey D, Le-Niculescu H et al (2015) Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions. Mol Psychiatry 20:286\u2013288. doi: 10.1038\/mp.2014.180","journal-title":"Mol Psychiatry"},{"key":"4348_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","volume":"41","author":"SM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien SM, Scully P, Fitzgerald P et al (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41:326\u2013331. doi: 10.1016\/j.jpsychires.2006.05.013","journal-title":"J Psychiatr Res"},{"key":"4348_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0006-3223(02)01811-5","volume":"54","author":"BWJH Penninx","year":"2003","unstructured":"Penninx BWJH, Kritchevsky SB, Yaffe K et al (2003) Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 54:566\u2013572. doi: 10.1016\/S0006-3223(02)01811-5","journal-title":"Biol Psychiatry"},{"key":"4348_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nmeth.2015","volume":"9","author":"P Picotti","year":"2012","unstructured":"Picotti P, Aebersold R (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9:555\u2013566. doi: 10.1038\/nmeth.2015","journal-title":"Nat Methods"},{"key":"4348_CR39","unstructured":"Pinheiro J, Bates D, DebRoy S, et al. (2009) nlme: linear and nonlinear mixed effects models."},{"key":"4348_CR40","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.euroneuro.2012.09.009","volume":"23","author":"TR Powell","year":"2013","unstructured":"Powell TR, Schalkwyk LC, Heffernan AL et al (2013) Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. Eur Neuropsychopharmacol 23:1105\u20131114. doi: 10.1016\/j.euroneuro.2012.09.009","journal-title":"Eur Neuropsychopharmacol"},{"key":"4348_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31\u201341. doi: 10.1001\/2013.jamapsychiatry.4","journal-title":"JAMA Psychiatry"},{"key":"4348_CR42","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1176\/appi.ajp.162.6.1171","volume":"162","author":"MH Rapaport","year":"2005","unstructured":"Rapaport MH, Clary C, Fayyad R, Endicott J (2005) Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162:1171\u20131178. doi: 10.1176\/appi.ajp.162.6.1171","journal-title":"Am J Psychiatry"},{"key":"4348_CR43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jad.2011.02.020","volume":"137","author":"HG Ruh\u00e9","year":"2012","unstructured":"Ruh\u00e9 HG, Van Rooijen G, Spijker J et al (2012) Staging methods for treatment resistant depression. A Syst Rev J Affect Disord 137:35\u201345","journal-title":"A Syst Rev J Affect Disord"},{"key":"4348_CR44","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/appi.ajp.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR et al (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905\u20131917. doi: 10.1176\/appi.ajp.163.11.1905","journal-title":"Am J Psychiatry"},{"key":"4348_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1590\/S1807-59322011000100020","volume":"66","author":"M Sadeghi","year":"2011","unstructured":"Sadeghi M, Roohafza H, Afshar H et al (2011) Relationship between depression and apolipoproteins A and B: a case\u2013control study. Clinics (Sao Paulo) 66:113\u2013117. doi: 10.1590\/S1807-59322011000100020","journal-title":"Clinics (Sao Paulo)"},{"key":"4348_CR46","first-page":"288","volume":"26","author":"FM Schmidt","year":"2014","unstructured":"Schmidt FM, Kirkby KC, Himmerich H (2014) The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression\u2014report of two cases. Psychiatr Danub 26:288\u2013290","journal-title":"Psychiatr Danub"},{"key":"4348_CR47","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.euroneuro.2012.02.006","volume":"22","author":"A Schosser","year":"2012","unstructured":"Schosser A, Serretti A, Souery D et al (2012) European Group for the Study of Resistant Depression (GSRD)\u2014where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmacol 22:453\u2013468. doi: 10.1016\/j.euroneuro.2012.02.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"4348_CR48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"G Schwarz","year":"1978","unstructured":"Schwarz G (1978) Estimating the dimension of a model. Ann Stat 6:461\u2013464","journal-title":"Ann Stat"},{"key":"4348_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bbapap.2014.12.012","volume":"1854","author":"S Shao","year":"2015","unstructured":"Shao S, Guo T, Aebersold R (2015) Mass spectrometry-based proteomic quest for diabetes biomarkers. Biochim Biophys Acta 1854:519\u2013527. doi: 10.1016\/j.bbapap.2014.12.012","journal-title":"Biochim Biophys Acta"},{"key":"4348_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","volume":"18","author":"NM Simon","year":"2008","unstructured":"Simon NM, McNamara K, Chow CW et al (2008) A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 18:230\u2013233. doi: 10.1016\/j.euroneuro.2007.06.004","journal-title":"Eur Neuropsychopharmacol"},{"key":"4348_CR51","doi-asserted-by":"crossref","unstructured":"Stelzhammer V, Haenisch F, Chan MK, et al. (2014) Proteomic changes in serum of first onset, antidepressant drug-na\u00efve major depression patients. Int J Neuropsychopharmacol 1\u201310. doi: 10.1017\/S1461145714000819","DOI":"10.1017\/S1461145714000819"},{"key":"4348_CR52","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge R, Arnone D, Danese A et al (2015) Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 25:1532\u20131543","journal-title":"Eur Neuropsychopharmacol"},{"key":"4348_CR53","first-page":"23","volume-title":"When at first you don\u2019t succeed: sequential strategies for antidepressant nonresponders","author":"ME Thase","year":"1997","unstructured":"Thase ME, Rush AJ (1997) When at first you don\u2019t succeed: sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry, In, pp 23\u201329"},{"key":"4348_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"The Gene Ontology Consortium","year":"2000","unstructured":"The Gene Ontology Consortium (2000) Gene ontology: tool for the unification of biology. Nat Genet 25:25\u201329. doi: 10.1038\/75556","journal-title":"Nat Genet"},{"key":"4348_CR55","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"The Gene Ontology Consortium","year":"2015","unstructured":"The Gene Ontology Consortium (2015) Gene ontology consortium: going forward. Nucleic Acids Res 43:D1049\u2013D1056. doi: 10.1093\/nar\/gku1179","journal-title":"Nucleic Acids Res"},{"key":"4348_CR56","first-page":"222","volume":"26","author":"K Trevino","year":"2014","unstructured":"Trevino K, McClintock SM, McDonald Fischer N et al (2014) Defining treatment-resistant depression: a comprehensive review of the literature. Ann Clin Psychiatry 26:222\u2013232","journal-title":"Ann Clin Psychiatry"},{"key":"4348_CR57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"MH Trivedi","year":"2004","unstructured":"Trivedi MH, Rush AJ, Ibrahim HM et al (2004) The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psych. Psychol Med 34:73\u201382","journal-title":"Psychol Med"},{"key":"4348_CR58","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1073\/pnas.1104836108","volume":"108","author":"JL Warner-Schmidt","year":"2011","unstructured":"Warner-Schmidt JL, Vanover KE, Chen EY et al (2011) Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A 108:9262\u20139267. doi: 10.1073\/pnas.1104836108","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4348-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4348-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T23:27:16Z","timestamp":1692401236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4348-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,20]]},"references-count":58,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4348"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4348-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,20]]}}}